CUBI vs FRME
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CUBI presents a stark contradiction between explosive growth and deteriorating fundamental health. While the Piotroski F-Score of 2/9 indicates significant weakness in financial health, the stock is fundamentally undervalued, trading well below its Graham Number ($105.14) and Intrinsic Value ($234.23). Massive YoY earnings growth (579.30%) and a low P/E of 9.37 provide a strong value proposition, but the bearish technical trend (10/100) and poor health score suggest high risk. The overall outlook is neutral until the underlying health metrics stabilize.
FRME presents as a classic value play with a stable Piotroski F-Score of 4/9 and a Graham Number of $60.54, suggesting the stock is significantly undervalued relative to its defensive fair value. However, this value is offset by negative year-over-year revenue (-4.60%) and earnings growth (-10.90%), alongside a bearish technical trend and insider selling. While the company consistently beats earnings estimates and maintains a healthy dividend payout ratio, the disconnect between its intrinsic value ($26.6) and current price ($40.36) indicates a lack of growth catalysts.
Compare Another Pair
Related Comparisons
CUBI vs FRME: Head-to-Head Comparison
This page compares Customers Bancorp, Inc. (CUBI) and First Merchants Corporation (FRME) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.